• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT INSULIN Back to Search Results
Catalog Number 08K41-26
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/13/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient demographic information provided by the customer.
 
Event Description
The customer reported falsely elevated architect insulin results on one patient.The results provided were initial insulin result when in the er = 4200miu/ml.The insulin is being tested every 30 minutes and the last value provided was 16miu/ml.There was no reported impact to patient management.
 
Manufacturer Narrative
Suspect medical device lot # from 85020lp07 to 08020lp35 a review of tickets determined that there are no other complaints for lot 08020lp35 and there were no trends identified for the product for the issue.Return testing was not completed as returns were not available.Accuracy testing was performed with a retained kit of lot 08020lp35 and an internal insulin panel.All acceptance criteria were met, which indicates acceptable product performance.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation no product deficiency was identified for the architect insulin reagent, lot 08020lp35.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN
Type of Device
INSULIN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key9539783
MDR Text Key221318651
Report Number1415939-2020-00001
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/13/2020
Device Catalogue Number08K41-26
Device Lot Number08020LP35
Was Device Available for Evaluation? No
Date Manufacturer Received01/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER,; ARCHITECT I2000SR ANALYZER, LN 03M74-01,; LN 03M74-01, SERIAL # (B)(6); SERIAL # (B)(6)
Patient Age55 YR
-
-